Moderna, Inc. (NASDAQ:MRNA) | Finanzwire

Basculer en Français

10224	Companies
210874	Keywords
140833	Articles
111722	Press releases

Home
Companies
Moderna, Inc.

PRESS RELEASE

published on 02/14/2025 at 12:28, 1 year 2 months ago

Moderna Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Provides Business Updates
Moderna, Inc. reports Q4 revenues of $1.0B with a net loss of $(1.1)B. Forecasts 2025 revenue of $1.5-2.5B. Submitted 3 mRNA products for regulatory approval. Financial details and pipeline updates disclosed

Revenues Net Loss Moderna MRNA Products 2025 Revenue
BRIEF

published on 01/29/2025 at 13:05, 1 year 2 months ago

Moderna to Announce Financial Results for Q4 and 2024

Financial Results Webcast Corporate Update MRNA Technology Moderna
PRESS RELEASE

published on 01/29/2025 at 13:00, 1 year 2 months ago

Moderna to Report Fourth Quarter and Full Year 2024 Financial Results on Friday, February 14, 2025
Moderna, Inc. to host conference call on February 14, 2025 to report Q4 and full year 2024 financial results, and provide a corporate update. Details on webcast available on Moderna website

Financial Results Conference Call Webcast Moderna Inc. MRNA Medicine
BRIEF

published on 01/24/2025 at 12:35, 1 year 2 months ago

Moderna Secures EU Tender for mRNA COVID-19 Vaccine Supply

COVID-19 Moderna MRNA Vaccine Spikevax EU Tender
PRESS RELEASE

published on 01/24/2025 at 12:30, 1 year 2 months ago

Moderna Awarded Tender for the Supply of Its mRNA COVID-19 Vaccine in the European Union
Moderna awarded tender to supply mRNA COVID-19 vaccine in EU, Norway, and North Macedonia, offering diverse formats like prefilled syringes. Enhancing vaccination campaigns with efficient options

COVID-19 Moderna MRNA Vaccine Vaccination Campaigns Prefilled Syringes
BRIEF

published on 01/17/2025 at 22:33, 1 year 2 months ago

Moderna Advances mRNA-Based Influenza Vaccine Development

Clinical Trials Moderna MRNA Vaccines BARDA Funding Influenza
PRESS RELEASE

published on 01/17/2025 at 22:28, 1 year 2 months ago

Moderna Announces Updates on Pandemic Influenza Program
Moderna announces ongoing support from HHS to accelerate mRNA-based pandemic influenza vaccines development. Award received through BARDA-funded RRPV Consortium

Moderna MRNA BARDA HHS Pandemic Influenza Vaccines
BRIEF

published on 01/13/2025 at 13:05, 1 year 3 months ago

Moderna Outlines Strategic Moves at J.P. Morgan Healthcare Conference

Cost Reduction Plan Vaccine Approvals Moderna Financials 2025 Revenue Forecast Pipeline Milestones
PRESS RELEASE

published on 01/13/2025 at 13:00, 1 year 3 months ago

Moderna Provides Business and Pipeline Updates at 43rd Annual J.P. Morgan Healthcare Conference
Moderna, Inc. announces 2024 financial achievements and 2025 projections with emphasis on revenue growth, cost reductions, and pipeline milestones including COVID-19 and flu vaccines

Revenue Growth Financial Updates Moderna Cost Reductions Pipeline Milestones
BRIEF

published on 11/25/2024 at 13:05, 1 year 4 months ago

Moderna to Present at December 2024 Investor Conferences

Investor Conferences Healthcare Webcast MRNA Technology Moderna

Accesswire

Published on 04/16/2026 at 01:50, 7 hours 55 minutes ago

Challenger DFS Pit Optimisation Drilling Complete
Published on 04/15/2026 at 23:00, 10 hours 45 minutes ago

EV Nickel Intersects 1.20% Nickel Over 9.80 Metres at Langmuir South
Published on 04/15/2026 at 22:30, 11 hours 15 minutes ago

Avant Brands Announces its Annual General and Special Meeting
Published on 04/15/2026 at 22:15, 11 hours 30 minutes ago

APPULSE CORPORATION (Listed on the TSX Venture Exchange - Symbol 'APL') - Reporting Results for the 2025 Fiscal Year and Adoption of Semi-annual Reporting
Published on 04/15/2026 at 22:00, 11 hours 45 minutes ago

NioCorp to Participate in Maxim Group's "Mining the Industrial Supply Chain" Conference on Apr. 21

View all ACCESSWIRE

EQS Group

Published on 04/16/2026 at 09:35, 10 minutes ago

COSRX Outshines Global Giants to Seize No. 1 Spot in Amazon UK Sunscreen Rankings
Published on 04/16/2026 at 09:10, 35 minutes ago

Finexity AG: FINEXITY Group starts the 2026 financial year with strong growth - scaling effects confirm strategic direction
Published on 04/16/2026 at 09:05, 40 minutes ago

Sigenergy Successfully Listed on HKEX with Strong Backing from Top-Tier Global Investors
Published on 04/16/2026 at 09:01, 44 minutes ago

Original-Research: ZEAL Network SE (von NuWays AG): BUY
Published on 04/16/2026 at 09:01, 44 minutes ago

Original-Research: MLP SE (von NuWays AG): BUY

Les Echos

Published on 04/16/2026 at 08:45, 1 hour ago

Air Liquide invests 200 million euros in Japan to support a leading semiconductor manufacturer in the production of next-generation AI chips
Published on 04/16/2026 at 08:30, 1 hour 15 minutes ago

Availability of the preparatory documents for the 2026 Combined General Meeting
Published on 04/15/2026 at 20:12, 13 hours 33 minutes ago

Covivio - Q1 2026 activity : Strategic progress driving growth
Published on 04/15/2026 at 18:43, 15 hours 2 minutes ago

SFPI GROUP: publication des résultats 2025
Published on 04/15/2026 at 17:45, 16 hours ago

Disclosure of Share Capital and Voting Rights Outstanding as of March 31, 2026

View all LES ECHOS COMFI WIRE